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herpetic keratitis
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Marcella Cintorino2 and Sergio A Tripodi2Abstract
Background: Translationally Controlled Tumour protein is a multifunctional calcium binding protein which has an
important role in apoptosis, calcium levels balance and immunological response. The aim of this study was to
evaluated the presence and distribution of TCTP in healthy human corneas and to identify and characterize the
presence and distribution of this protein in human normal cornea. Since recent studies suggest that apoptosis,
calcium levels and immunological mechanisms play a role in the pathogenesis of herpetic stromal keratitis, we
studied TCTP expression in this disease.
Methods: We evaluated the expression of TCTP at both RNA messanger and protein level by using reverse
transcriptase analysis, immunoblotting and immunohistochemistry in 10 healthy samples cornea: four obtained after
penetrating keratoplasty and six from eyes enucleated for other pathologies. Finally, we analysed by
immunohistochemistry ten paraffin-embedded samples of Herpes simplex virus keratitis collected at Siena
Department of Human Pathology and Oncology: 5 had clinically quiescent disease and 5 had active corneal
inflammation.
Results: Reverse transcriptase and immunoblotting demonstrated TCTP expression in cornea as a 22,000 Da
molecular weight band corresponding to the molecular weight of this protein. Immunohistochemically, all the
layers of normal corneal epithelium showed TCTP cytoplasmic expression. TCTP was, also, observed in keratocytes
and in the endothelium. In Herpes simplex virus keratitis samples, strong expression of TCTP was evident in stromal
cells, in the inflammatory infiltrate and in neo-vessels.
Conclusions: In this preliminary study we demonstrated, for the first time, the presence of TCTP in human cornea,
suggesting a potential role in the pathogenesis of herpes virus keratitis.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/3306813447428149Background
Translationally controlled tumour protein (TCTP), also
known as fortilin [1] or TPT1 [2] is a ubiquitously
expressed protein of 21 kDa in mice and 23 kDa in
humans, expressed in all eukaryotes. It bears no se-
quence similarity with any other known protein [1]. It is
encoded by a gene that maps to chromosome 13q14.13* Correspondence: maradot@libero.it
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reproduction in any medium, provided the or[1,3] and its expression is highly regulated at transcrip-
tional and translational level and by a wide range of
extracellular signals. Its name originates from the obser-
vation that TCTP transcripts accumulate in resting cells
and are rapidly translated into the protein when the cells
require it [4]. Although TCTP was first considered a
tumour protein [5], its expression is not limited to can-
cer, as it has been found in normal cells and tissues [6].
Since its discovery by Yenofsky [7], it has become clear
that TCTP is a multifaceted protein, implicated in many
biological processes and exerting biological activity attd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A-B. The surgical specimen. Peripheral corneal tissue
obtained after penetrating keratoplasty.
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pates in cell growth, cell cycle progression, division and
proliferation [8]. An anti-apoptotic function of TCTP in
human cancer cells has also been identified. This func-
tion may be related to calcium binding [9-12] and inhib-
ition of Bax dimerization [4]. The interaction between
TCTP and p53 prevents apoptosis by destabilizing p53
[13]. TCTP is also considered a heat shock protein with
chaperone-like activity [14]. It functions as an IgE-
dependent histamine releasing factor, having cytokine-
like activity in acute allergic response and being involved
in immunological response [15]. Association with a cyto-
skeletal component, F-actin, and a role in cell shape
regulation were also recently discovered [16], as well as
its capacity to bind tubulin and serve as a substrate for
Polo-like kinase 1 (Plk-1) [4].
Ocular vision depends on corneal transparency and
shape. These properties depend on the balance between
cell proliferation and apoptosis, both mechanisms regu-
lated by TCTP [17]. The presence and distribution of
TCTP in the human cornea has not yet been fully ana-
lysed. Studies in the literature have used proteomic tech-
niques and been limited to cultured keratocytes [18].
Here we evaluated the presence and distribution of
TCTP in healthy human corneas for the first time by
immunoblotting, reverse transcriptase analysis and
immunohistochemistry. Since recent studies suggest that
apoptosis [19], calcium levels [20] and immunological
mechanisms [21] play a role in the pathogenesis of her-
petic stromal keratitis (HSK), we studied TCTP expres-
sion in this disease.
Materials and methods
Ethics Statement
Ethics approval for this study was obtained from the Insti-
tutional Review Board at the University of Siena (Italy).
Informed written consent was obtained in all cases.
Patients
We used 10 samples of healthy corneal tissue, four
obtained after penetrating keratoplasty (PKP) and six
from eyes enucleated for retinoblastoma, in which the
anterior segment was tumor-free. Ten other corneal tis-
sue samples were collected from patients undergoing
PKP for sequelae of HSK. The diagnosis of HSK was
based on clinical and slit lamp findings. PKPs were per-
formed consecutively from August 2010 to December
2011.
Tissue preparation
The surgical specimens obtained after PKP were grossly
examined and halved (Figure 1A-B). Half of the samples
were rinsed in sterile HBSS (Hanks balanced salt solu-
tion) at room temperature, blotted dry and dissectedwith a razor blade. To analyse protein and RNA, they
were snap-frozen and stored in liquid nitrogen. The
other half were fixed in 10% buffered formalin and em-
bedded in paraffin. From paraffin-embedded blocks of
PKP and enucleation samples, 4-μm-thick sections were
obtained and processed for histology and immunohisto-
chemistry. Anti-human TCTP mouse monoclonal anti-
body was prepared as previously described [22].
Western blot analysis
Frozen corneal tissue samples were thawed, reduced
to small pieces with a razor blade and homogenized
on ice with a Polytron blender (Kinematica, Lucerne,
Switzerland) in lysis buffer [50 mMTris–HCl, 5 mM mag-
nesium acetate, 0.2 mM EDTA, 0.5 mMdithiothreitol, 10%
(vol/vol) glycerol, 0.2% (vol/vol) Triton X-100 (pH 7.5)]
supplemented with a protease-inhibitor cocktail (Sigma
Chemical Co, Milan-Italy), three times for 20 seconds
each. Tissues were centrifuged at 750 x g for 10 min at 4°
C and the supernatant assayed for total protein content
and stored at −80°C. Western blot analysis was carried out
as previously described [23].
Detection of TCTP mRNA
Total RNA was extracted using the method of Chomc-
zynski and Sacchi. Frozen tissues were crushed with a
pestle and homogenized in Tri-Reagent (Life Technolo-
gies, Monza-Italy) with a Polytron blender (Kinematica,
Luzern-Switzerland). Cell pellets were thawed and im-
mediately lysed with Tri-Reagent. RNA extraction was
carried out as recommended by the manufacturer. TCTP
mRNA was detected by reverse transcriptase-polymerase
chain reaction (RT-PCR) as previously described [23].
The products were separated by 2.0% agarose gel elec-
trophoresis, visualized by ethidium bromide staining,
and photographed.
Immunohistochemical analysis
Immunohistochemistry was performed using the alkaline
phosphatase–anti-alkaline-phosphatase (APAAP) method.
Sections were dewaxed, rehydrated and washed in Tris-
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7.6)]. Antigen retrieval was carried out by incubating sec-
tions in sodium citrate buffer (10 mM, pH 6.0) in a micro-
wave oven at 750 W for 5 min. Sections were incubated
with an anti-human TCTP monoclonal antibody diluted
1:100 in TBS overnight at 4°C. Slides were washed and
incubated for 30 min with a rabbit anti-mouse antibody
(Dako, Milan, Italy, dilution 1:30) and finally incubated for
30 min with APAAP complex (Dako, dilution 1:50) in
TBS. The alkaline phosphatase reaction was detected
using fuchsin and naphthol. TCTP expression was evalu-
ated semiquantitatively by HSCORE, as previously
described [24]. Placental tissue served as external positive
control [10].Statistical analysis
Statistical analysis was performed using a statistical soft-
ware package (SYSTAT-7). Differences in TCTP pattern
between cases grouped according to inflammation and
neovascularization (groups 1 and 2) were analysed using
the Chi-square test and Fisher’s exact test. Statistical sig-
nificance was set at P ≤ 0.05.Results
Normal cornea
RT-PCR analysis of TCTP mRNA levels
To evaluate steady-state levels of TCTP mRNA, total
RNA extracted from tissues was examined by RT-PCR.
When amplification was carried out in the presence of
human TCTP primers, an intense band corresponding
to the TCTP product was obtained on the agarose gel
from the cDNA of each corneal tissue specimen
(Figure 2).Figure 2 RT-PCR analysis of TCTP mRNA levels in the 10
samples. One microgram of total RNA was reverse transcribed and
amplified in the presence of TCTP primers. Thirty cycles were run for
both PCRs. The size of the MW markers is indicated. B, blank.Western blot analysis
To further confirm the presence of TCTP in our speci-
mens, Western blot analysis was carried out. After frac-
tionation on SDS–PAGE, proteins of all specimen
homogenates were blotted onto nitrocellulose and the fil-
ter exposed to an anti-TCTP antibody. A single band of
the approximate molecular weight (MW) of 22,000 Da
was detected in all specimens (Figure 3). Staining was
abolished by probing blots identical to those described
above with the antibody pre-absorbed with recombinant
TCTP. Control tissue was represented by placenta, as pre-
viously described [10].
Immunohistochemistry
Immunohistochemical analysis performed with the anti-
TCTP antibody showed cytoplasmic staining. TCTP ex-
pression was observed in the basal (Figure 4A) and
intermediate (Figure 4B) cell layers of corneal epithelium
with HSCOREs of 2 and 1, respectively. TCTP was also
evident in keratocytes and endothelial cells with a
HSCORE of 1 (Figure 4B, inset).
HSK
Of the 10 specimens from patients with HSK, 5 had ac-
tive keratitis (moderate to severe inflammation and neo-
vascularization) and 5 had quiescent disease (absent or
mild inflammation). In the active HSK samples, intense
and diffuse (HSCORE 3) TCTP staining was observed in
stromal cells throughout all layers of the cornealFigure 3 Western blot profile. Twenty micrograms of total protein
were loaded onto 12% polyacrylamide gel, fractionated, blotted
onto nitrocellulose and exposed overnight to an anti-TCTP antibody.
The position of MW markers, in kDa, is indicated. Control tissue was
placenta.
Figure 4 Immunohistochemical profile of healthy corneal
tissue. Positive TCTP staining was observed in the basal and
intermediate cell layers of the corneal epithelium (A-B); weak and
focal staining was observed in keratocytes and along the endothelial
cell layer (B, inset) [A, original magnification (O.M) 2.5x; B, O.M. 5x;
inset, O.M. 2.5x].
Figure 5 Immunohistochemical profile of corneal tissue with
HSK. In active keratitis, strong TCTP staining was observed
throughout all layers of the corneal epithelium, as well as in stromal
cells (A-B), whereas in quiescent disease little or no expression was
present (A, inset) [A, O.M 10x; B, O.M. 20x; inset, O.M. 20x].
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ples, TCTP expression was weak (HSCORE 1), present
only in corneal epithelium with little or no immunohis-
tochemical expression in the stroma (Figure 5A, inset)
(p = 0.001).
Discussion
TCTP is a highly conserved, ubiquitously expressed pro-
tein involved in multiple biological activities, including
apoptosis [13]. An extensive review of the literature
showed that previous studies on TCTP in the cornea
used proteomics techniques were limited to cultured
keratocytes [18]. In the present study we demonstrated
the presence of TCTP in human corneal tissue by RT-
PCR and immunoblotting, and confirmed these findings
by immunohistochemistry using an antibody against
TCTP. Since apoptosis plays a key role in HSK and is
controlled by TCTP, we also attempted to find a patho-
genic correlation between TCTP and HSK, evaluating
TCTP expression in corneal samples with HSK. TCTP
inhibited the proapoptotic proteins Bax and BCLxL, pro-
moters of membrane attack complex (MAC) pore
formation via dimerization of the mitochondrial mem-
brane. TCTP inserts itself in the mitochondrial mem-
brane, preventing Bax from dimerizing. This inhibits
MAC pore formation and prevents any flux of apoptosis
promoting factors into the cell. TCTP also binds to Mcl-
1, stabilizing it and enhancing its anti-apoptotic activity.
In addition, TCTP was shown to bind p53 and prevent
apoptosis by destabilizing the protein and repressing
transcription of p53 [4]. A correlation was found be-
tween the degree of inflammation and expression of
TCTP in corneal epithelium, as well as in inflammatory
infiltrate in HSK patients with active disease [25]. In the
case of mild inflammation, we found low expression of
TCTP, limited to neovessels and keratinocytes. These
results suggest a double role of TCTP in herpes keratitis:
as an antiapoptotic protein in corneal cells and as a
cytokine-like protein in the stroma, where TCTP may be
secreted by inflammatory cells, probably monocytes, in
the extracellular milieu. Apoptosis has been shown to
limit viral invasion: corneal infection with wild-type
virus results in apoptosis of a number of infected epithe-
lial cells [26]. Primary herpes simplex virus-1 (HSV-1)
corneal infection stimulates apoptosis of anterior kerato-
cytes in the stroma underlying the site of epithelial in-
jury. TCTP may modulate the keratocyte apoptotic
response, limiting stromal damage as well as triggering
the keratocyte apoptotic response via soluble mediators
released by epithelial injury secondary to corneal HSV-1
infection. Considering the importance of apoptosis as a
general mechanism for eliminating normal and patho-
logically altered cells, manipulation of apoptosis may
offer new possibilities for treating HSK.
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cellular stroma of actively inflamed HSK, which is in line
with previous studies on broncho-alveolar lavage fluids
of patients with eosinophilic pneumonia and asthma
[27,28]. A mechanism by which extracellular TCTP
might intervene through cytokine-like activity in the
complex pathogenesis of HSK is by regulating the
immune-mediated response to herpes simplex virus. In
fact, HSK is currently thought to be an immune-
mediated disease. CD4 positive Th1 cells are involved in
the development of inflammatory HSK corneal lesions:
infiltration of CD4 positive Th1 cells into the cornea
causes release of cytokines, mainly interleukin (IL)-2 and
interferon (IFN)-γ, which elicit an inflammatory re-
sponse and recruit neutrophils and macrophages. TCTP
is known to inhibit the release of IL-2 in human periph-
eral blood T cells and Jurkat T cells [29] and a role of
TCTP in the modulation of T regs apoptosis/survival
was recently demonstrated [30].
Repair of damage after each infection progressively
impairs the biomechanical properties of the cornea. The
repair process or wound healing of corneal epithelium is
complex, including cell migration, proliferation and dif-
ferentiation, all of which depend on calcium-mediated
signals [31]. Calcium concentrations vary during wound
healing, thus inducing variations in cell motility, morph-
ology and adhesion that are all essential to the process
[32]. Calcium levels are regulated by TCTP [6].
Conclusions
In this study we demonstrated the presence and distri-
bution of TCTP in human corneal tissue and its expres-
sion in HSK, probably related to inflammation and
neovascularization. These findings suggest a multifunc-
tional role of TCTP in corneal wound healing, HSV-1
corneal infection, IgE-mediated hypersensitivity reac-
tions and maintenance of corneal transparency and
shape [16] by interaction with cytoskeletal proteins. Fur-
ther in vivo and in vitro studies are needed to fully
understand the pathophysiological roles of TCTP in cor-
neal diseases, considering that only 20 samples were
tested for TCTP and that no data on its role in HSK and
other types of keratitis are available in the literature.
Since a series of pharmaceutical compounds decrease
TCTP expression by down-regulation of its expression
at protein level, broader studies may help to determine
whether TCTP may act as a target for drugs, contribut-
ing to new alternatives for the treatment of HSK, avoid-
ance of complications and reduction of relapses [33].
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